Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

The head of the FDA’s artificial-intelligence-focused Digital Center of Excellence, Troy Tazbaz, is departing the agency during what he described as the early stages of a “technological ...

the head of the FDA [Food and Drug Administration], potentially Martin McElroy. That's really important because that's kind of the critical agency for the biopharma sector." ...

Several executive orders recently signed by US President Donald Trump may have significant implications for the US Food and Drug Administration ...

Robert F. Kennedy Jr. vows to finalize regulations for greater diverse patient involvement in clinical trials during his ...